Eiger BioPharmaceuticals, Inc

Nabi Biopharmaceuticals develops and markets products that fight serious medical conditions. The company focuses on developing products that address commercial opportunities. Its main business areas encompass Gram-positive bacterial infections, hepatitis, kidney disease and nicotine addiction. Nabi Biopharmaceuticals product brands include PhosLo, Nabi-HB and Aloprim along with a number of products in various stages of clinical and pre-clinical development. Nabi Biopharmaceuticals maintains its international headquarters in Boca Raton, Fla., with principal research and development offices and laboratories in Rockville, Md. The company's European headquarters, Nabi Biopharmaceuticals Europe Limited, is located in Bray, Ireland.

OncoMed Pharmaceuticals, founded in 2004, is a biotechnology company that deals in providing cancer treatment for individuals. The company conducts cancer stem cell research programs and has established a library of antibodies for the treatment of solid tumors, such as pancreatic, breast, colorectal and lung cancer. It is a privately owned company that receives funds from a group of investors, including US Venture Partners, Latterell Venture Partners(LVP), The Vertical Group, Morgenthaler Ventures, Nomura Phase4 Ventures Limited, Delphi Ventures, Adams Street Partners, De Novo Ventures and Bay Partners. OncoMed Pharmaceuticals OncoMed has established various technologies for the detection, isolation and characterization of tumor initiating cells. The company has tested more than 150 antibodies.

Codexis is one of the leaders in the development of innovative bio-based solutions for pharmaceutical chemical process development and manufacturing. The company s unique protein and strain engineering technology platform creates superior biological catalysts either enzymes or fermentation strains crafted specifically for cutting-edge chemical processes that can enable pharmaceutical process development, shorten process development timelines and dramatically improve existing manufacturing processes. Codexis has more than 12 strategic alliances, including a major collaboration with Pfizer, and more than 20 products and processes in development internally and at leading worldwide life sciences companies. It began operations as an independent company in 2002. Codexis is headquartered in Redwood City, Calif.